Literature DB >> 8548346

Bacteremia in hospitalized patients infected with the human immunodeficiency virus: a case-control study of risk factors and outcome.

C J Fichtenbaum1, W C Dunagan, W G Powderly.   

Abstract

We reviewed all episodes of nonmycobacterial bacteremias in human immunodeficiency virus (HIV)-infected patients from 1990 to 1991 to determine the incidence, risk factors, and outcome. Forty-five patients had a total of 63 episodes of bacteremia (9% of 689 HIV-related hospitalizations). In this cohort, the median CD4+ lymphocyte count was 17 cells/mm3, 71% had AIDS, and 78% were homosexual men. The most frequently isolated bacteria were Staphylococcus aureus (25%) and coagulase-negative staphylococci (22%). The most common site of infection was intravenous catheter-related, accounting for 35% of the bacteremias. Compared to HIV-infected, nonbacteremic controls, patients with bacteremia detected at admission were more likely to have an indwelling intravenous catheter (p = 0.003) and less likely to be likely zidovudine (p = 0.04). The overall in-hospital mortality rate was 24%. There was no significant difference in the in-hospital mortality rates in bacteremic patients with or without HIV infection. Seventeen patients had more than one episode of bacteremia (71% had recurrence with the same organism). We conclude that bacteremia is a significant problem in HIV-infected persons with low CD4+ lymphocyte counts, often related to the presence of an intravenous catheter; recurrence is common. In addition, HIV infection does not appear to increase the mortality rate for bacteremia.

Entities:  

Mesh:

Year:  1995        PMID: 8548346

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  7 in total

1.  Pseudomonas spp. complications in patients with HIV disease: an eight-year clinical and microbiological survey.

Authors:  R Manfredi; A Nanetti; M Ferri; F Chiodo
Journal:  Eur J Epidemiol       Date:  2000-02       Impact factor: 8.082

Review 2.  Staphylococcal skin infections in children: rational drug therapy recommendations.

Authors:  Shamez Ladhani; Mehdi Garbash
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

3.  Bloodstream infections among human immunodeficiency virus-infected adult patients: epidemiology and risk factors for mortality.

Authors:  M Ortega; M Almela; A Soriano; F Marco; J A Martínez; A Muñoz; G Peñarroja; J Mensa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-01       Impact factor: 3.267

4.  Determination of the underlying cause of death in three multicenter international HIV clinical trials.

Authors:  Alan R Lifson; Waldo H Belloso; Cate Carey; Richard T Davey; Daniel Duprez; Wafaa M El-Sadr; Jose M Gatell; Daniela C Gey; Jennifer F Hoy; Eric A Krum; Ray Nelson; Daniel E Nixon; Nick Paton; Court Pedersen; George Perez; Richard W Price; Ronald J Prineas; Frank S Rhame; James Sampson; John Worley
Journal:  HIV Clin Trials       Date:  2008 May-Jun

5.  The incidence of and risk factors for MRSA bacteraemia in an HIV-infected cohort in the HAART era.

Authors:  M D Burkey; L E Wilson; R D Moore; G M Lucas; J Francis; K A Gebo
Journal:  HIV Med       Date:  2008-08-21       Impact factor: 3.180

6.  Trends in annual incidence of methicillin-resistant Staphylococcus aureus (MRSA) infection in HIV-infected and HIV-uninfected patients.

Authors:  G N Delorenze; M A Horberg; M J Silverberg; A Tsai; C P Quesenberry; R Baxter
Journal:  Epidemiol Infect       Date:  2013-02-18       Impact factor: 4.434

7.  Bacteremia in hospitalized patients with human immunodeficiency virus: A prospective, cohort study.

Authors:  B Afessa; I Morales; B Weaver
Journal:  BMC Infect Dis       Date:  2001-09-07       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.